According to the latest research by the company, the global vagus nerve stimulator market is projected to account for over US$ 1.129.5 Mn, in terms of value, by 2028 end.

"Vagus nerve stimulation lowers costs of care for children with uncontrolled epilepsy." ScienceDaily. ScienceDaily, 25 March 2022. <www.sciencedaily.com / releases / 2022 / 03 / 220325122651.htm>.

Transcutaneous auricular vagus nerve stimulation in the treatment of disorders of consciousness: mechanisms and applications. Frontiers in Neuroscience. DOI= 10.3389/fnins.2023.1286267 ...

I tested the Truvaga Plus, a handheld vagus-nerve stimulator, to see if it could reduce stress and improve sleep. Here's my experience.

The vagus nerve also regulates vocalization, mood, and immunity. It influences sensory functions in a person’s ears, sinuses, and esophagus as well. Learn more about the vagus nerve here.

U.S. Patent No. 11,766,562 entitled “Nerve Stimulator for Use with a Mobile Device” was issued on September 26, 2023, and is generally related to treating seizures, such as epileptic seizures ...

Vagus nerve stimulation devices may help improve workouts, sleep, and mood. Writer Tianna Soto tried the Truvaga Plus for two weeks—here's how it went.

The trial was investigating the use of vagus nerve stimulation (VNS) for inflammatory bowel disease (IBD), an autoimmune condition that includes ulcerative colitis and Crohn’s disease.

Curious but unconvinced, I recently tested the Truvaga 350, a vagus nerve stimulator you can use anywhere, at any time, for just two minutes twice a day. Here’s what I found out.

The FDA has expanded the label for the gammaCore vagus nerve stimulator to include treatment of acute pain from migraine in addition to the previously cleared treatment of episodic cluster headache.